PT MITSUBISHI TANABE PHARMA IN

PT Mitsubishi Tanabe Pharma Indonesia is a factory.

Company Introduction:

PT Mitsubishi Tanabe Pharma Indonesia is a subsidiary of Mitsubishi Tanabe Pharma Corporation, a prominent Japanese pharmaceutical company. Established in Indonesia, the company operates as a manufacturing facility, specializing in the production, marketing, and distribution of a diverse portfolio of pharmaceutical products. It plays a significant role in the Indonesian healthcare sector by providing medicines across various therapeutic areas. The company is committed to upholding high quality standards in its manufacturing processes to ensure the efficacy and safety of its pharmaceutical offerings for the local market.

PT Mitsubishi Tanabe Pharma Indonesia produces or sells a range of pharmaceutical products, primarily in the therapeutic areas of central nervous system disorders, metabolic diseases, and inflammatory conditions.

Some of their key products include:

Remicade (Infliximab): Used for autoimmune diseases such as rheumatoid arthritis, Crohn's disease, and ulcerative colitis.

Kremezin (AST-120): Indicated for chronic kidney disease.

Talnetat (Mitiglinide): A medication for type 2 diabetes.

Livial (Tibolone): Prescribed for postmenopausal symptoms.

Teprotide (Cilazapril): An ACE inhibitor for hypertension.

They also offer various other products addressing neurological conditions, gastrointestinal disorders, and cardiovascular health.